This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Tandem Diabetes Care, Inc., Smiths Medical Asd, Inc.. Active years: 2013-2022.
Company Filing History:
Years Active: 2013-2022
Title: Kevin Sean Kopp: Innovator in Diabetes Therapy
Introduction
Kevin Sean Kopp is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of diabetes therapy, holding a total of 6 patents. His innovative work focuses on developing advanced devices and systems that enhance the management of diabetes.
Latest Patents
One of Kopp's latest patents is for a diabetes therapy coaching apparatus. This device comprises a pump, an input configured to receive information related to a user, a user interface, and a controller that is communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module that is designed to initiate the delivery of a drug in a timely manner and to adjust the delivery based on the received information. Other devices, systems, and methods are also disclosed in this patent.
Another significant patent by Kopp is for an infusion pump with a blood glucose alert delay. This apparatus includes a pump, a user interface, and a controller that is communicatively linked to both the pump and the user interface. The controller is capable of receiving information regarding a user's blood glucose level, determining if the level deviates from a target by a specified threshold, and selectively providing or delaying an alert to notify the user to check their blood glucose level. Additional devices, systems, and methods are also described in this patent.
Career Highlights
Throughout his career, Kopp has worked with prominent companies in the medical device industry, including Tandem Diabetes Care, Inc. and Smiths Medical ASD, Inc. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative diabetes management solutions.
Collaborations
Kopp has collaborated with several professionals in his field, including Michael L. Blomquist and Thomas Alan Savard. These collaborations have likely enriched his work and led to further advancements in diabetes therapy technologies.
Conclusion
Kevin Sean Kopp is a distinguished inventor whose work in diabetes therapy has made a significant impact on the management of this chronic condition. His innovative patents and career achievements reflect his dedication to improving the lives of individuals living with diabetes.